Maximum quantity allowed is 999
请选择数量
CAS RN: 82586-55-8 | 產品號碼: Q0082
Quinapril Hydrochloride
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | Q0082 |
| 純度/分析方法 | >98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__2__5H__3__0N__2O__5·HCl = 474.98 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Refrigerated (0-10°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Air Sensitive,Hygroscopic,Heat Sensitive |
| 包裝和容器 | 1G-Glass Bottle with Plastic Insert （閲覽圖片）, 250MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 82586-55-8 |
| Reaxys-RN | 5699760 |
| MDL編號 | MFCD00889215 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Neutralization titration) | min. 98.0 % |
| Specific rotation | +14.0 to +16.0 deg(C=2, methanol) |
| NMR | confirm to structure |
性質
| 熔點 | 130 °C |
| 溶解性（不溶於） | Diethyl ether |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H361 : Suspected of damaging fertility or the unborn child. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
相關法規
| RTECS # | NW7176000 |
運輸資料
| HS編碼* | 2933.49-000 |
Application
Quinapril Hydrochloride: A Non-Peptide, Non-Sulfhydryl Angiotensin- Converting Enzyme (ACE) Inhibitor
Angiotensin-converting enzyme (ACE) is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. Quinapril hydrochloride is an orally active, non-peptide, non-sulfhydryl angiotensin- converting enzyme (ACE) inhibitor. It is a prodrug and is de-esterified to the principal metabolite, quinaprilat, which is an inhibitor of ACE activity in human subjects and animals. The effects of quinapril in hypertension and in congestive heart failure (CHF) appear to result primarily from the inhibition of circulating and tissue ACE activity, thereby reducing angiotensin II formation. (The product is for research use only.)
References
- Quinapril—A Preclinical Review of the Pharmacology, Pharmacokinetics, and Toxicology
- Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders
- Quinapril: A further update of its pharmacology and therapeutic use in cardiovascular disorders
- Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching
- Determination of losartan potassium, quinapril hydrochloride and hydrochlorothiazide in pharmaceutical preparations using derivative spectrophotometry and chromatographic-densitometric method
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。